Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,092 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer.
Sung C, An J, Lee S, Park J, Lee KS, Kim IH, Han JY, Park YH, Kim JH, Kang EJ, Hong MH, Kim TY, Lee JC, Lee JL, Yoon S, Choi CM, Lee DH, Yoo C, Kim SW, Jeong JH, Seo S, Kim SY, Kong SY, Choi JK, Park SR. Sung C, et al. Among authors: kim ih, kim sw, kim ty, kim sy, kim jh. Nat Cancer. 2023 Jun;4(6):844-859. doi: 10.1038/s43018-023-00572-5. Epub 2023 Jun 12. Nat Cancer. 2023. PMID: 37308678
Preoperative chemoradiation with cetuximab, irinotecan, and capecitabine in patients with locally advanced resectable rectal cancer: a multicenter Phase II study.
Kim SY, Hong YS, Kim DY, Kim TW, Kim JH, Im SA, Lee KS, Yun T, Jeong SY, Choi HS, Lim SB, Chang HJ, Jung KH. Kim SY, et al. Among authors: kim tw, kim dy, kim jh. Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):677-83. doi: 10.1016/j.ijrobp.2010.06.035. Epub 2010 Oct 1. Int J Radiat Oncol Biol Phys. 2011. PMID: 20888703 Clinical Trial.
KRAS mutation status and clinical outcome of preoperative chemoradiation with cetuximab in locally advanced rectal cancer: a pooled analysis of 2 phase II trials.
Kim SY, Shim EK, Yeo HY, Baek JY, Hong YS, Kim DY, Kim TW, Kim JH, Im SA, Jung KH, Chang HJ. Kim SY, et al. Among authors: kim tw, kim dy, kim jh. Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):201-7. doi: 10.1016/j.ijrobp.2012.03.048. Epub 2012 Jun 5. Int J Radiat Oncol Biol Phys. 2013. PMID: 22672749 Clinical Trial.
Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer.
Lee KH, Chang HJ, Han SW, Oh DY, Im SA, Bang YJ, Kim SY, Lee KW, Kim JH, Hong YS, Kim TW, Park YS, Kang WK, Shin SJ, Ahn JB, Kang GH, Jeong SY, Park KJ, Park JG, Kim TY. Lee KH, et al. Among authors: kim tw, kim ty, kim sy, kim jh. Cancer Chemother Pharmacol. 2013 Apr;71(4):843-51. doi: 10.1007/s00280-013-2075-3. Epub 2013 Jan 13. Cancer Chemother Pharmacol. 2013. PMID: 23314736
Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping.
Kim HR, Lee SY, Hyun DS, Lee MK, Lee HK, Choi CM, Yang SH, Kim YC, Lee YC, Kim SY, Jang SH, Lee JC, Lee KY. Kim HR, et al. Among authors: kim sy, kim yc. J Exp Clin Cancer Res. 2013 Aug 9;32(1):50. doi: 10.1186/1756-9966-32-50. J Exp Clin Cancer Res. 2013. PMID: 23927790 Free PMC article.
S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial.
Kim ST, Hong YS, Lim HY, Lee J, Kim TW, Kim KP, Kim SY, Baek JY, Kim JH, Lee KW, Chung IJ, Cho SH, Lee KH, Shin SJ, Kang HJ, Shin DB, Lee JW, Jo SJ, Park YS. Kim ST, et al. Among authors: kim tw, kim kp, kim sy, kim jh. BMC Cancer. 2014 Nov 26;14:883. doi: 10.1186/1471-2407-14-883. BMC Cancer. 2014. PMID: 25424120 Free PMC article. Clinical Trial.
Spontaneous regression in advanced squamous cell lung carcinoma.
Park YH, Park BM, Park SY, Choi JW, Kim SY, Kim JO, Jung SS, Park HS, Moon JY, Lee JE. Park YH, et al. Among authors: kim jo, kim sy. J Thorac Dis. 2016 Mar;8(3):E235-9. doi: 10.21037/jtd.2016.02.19. J Thorac Dis. 2016. PMID: 27076978 Free PMC article.
12,092 results
You have reached the last available page of results. Please see the User Guide for more information.